Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
- PMID: 25657753
- PMCID: PMC4310081
Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
Abstract
Background: No-reflow phenomenon after percutaneous coronary intervention (PCI) in patients with acute ST-segment-elevation myocardial infarction (STEMI) is relatively common and has therapeutic and prognostic implications. Cigarette smoking is known as deleterious in patients with coronary artery disease (CAD), but the effect of smoking on no-reflow phenomenon is less investigated. The aim of this study was to compare no-reflow phenomenon after percutneous coronary intervention for acute myocardial infarction, between smokers and non smokers.
Materials and methods: A total of 141 patients who were admitted to Chamran Hospital (Isfahan, Iran) between March and September, 2012 with a diagnosis of STEMI, enrolled into our Cohort study. Patients were divided into current smoker and nonsmoker groups (based on patient's information). All patients underwent primary PCI or rescue PCI within the first 12-h of chest pain. No-reflow phenomenon, thrombolysis in myocardial infarction (MI) flow, and 24-h complications were assessed in both groups.
Results: A total of 47 current smoker cases (32.9%) and 94 (65.7%) nonsmoker cases were evaluated. Smokers in comparison to nonsmokers were younger (53.47 ± 10.59 vs. 61.46 ± 10.55, P < 0.001) and they were less likely to be hypertensive (15.2% vs. 44.7%, P < 0.001), diabetic (17% vs. 36.2%, P < 0.05), and female gender (4.3% vs. 25.5%, P < 0.01). Angiographic and procedural characteristics of both groups were similar. 9 patients died during the first 24-h after PCI (4.3% of smokers and 6.4% of nonsmokers, P: 0.72). No-reflow phenomenon was observed in 29.8% of current smokers and 31.5% of nonsmokers (P = 0.77).
Conclusion: No-reflow phenomenon or short-term complications were not significantly different between current smokers and non smokers.
Keywords: Cigarette smoking; no-reflow phenomenon; primary percutaneous coronary intervention; thrombolysis in myocardial infarction flow.
Conflict of interest statement
Similar articles
-
Effects of streptokinase on reflow in rescue percutaneous coronary intervention.ARYA Atheroscler. 2013 Jan;9(1):22-8. ARYA Atheroscler. 2013. PMID: 23696756 Free PMC article.
-
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27. Cardiol J. 2016. PMID: 26503078
-
The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.J Clin Lab Anal. 2018 Nov;32(9):e22598. doi: 10.1002/jcla.22598. Epub 2018 Jun 26. J Clin Lab Anal. 2018. PMID: 29943408 Free PMC article.
-
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.Indian Heart J. 2016 Jul-Aug;68(4):539-51. doi: 10.1016/j.ihj.2016.04.006. Epub 2016 Apr 19. Indian Heart J. 2016. PMID: 27543480 Free PMC article. Review.
-
Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention.Rev Cardiovasc Med. 2023 Dec 25;24(12):365. doi: 10.31083/j.rcm2412365. eCollection 2023 Dec. Rev Cardiovasc Med. 2023. PMID: 39077094 Free PMC article. Review.
Cited by
-
Efficacy of combined endurance-resistance training versus endurance training in patients with heart failure after percutaneous coronary intervention: A randomized controlled trial.J Res Med Sci. 2018 Feb 20;23:12. doi: 10.4103/jrms.JRMS_743_17. eCollection 2018. J Res Med Sci. 2018. PMID: 29531564 Free PMC article.
-
Case Report: Smoking as the risk factor of persistent STEMI after primary percutaneous coronary intervention: how it could be happen?F1000Res. 2024 Oct 29;11:801. doi: 10.12688/f1000research.109757.3. eCollection 2022. F1000Res. 2024. PMID: 39493285 Free PMC article.
-
Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts.ARYA Atheroscler. 2017 Sep;13(5):221-229. ARYA Atheroscler. 2017. PMID: 29371868 Free PMC article.
-
Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention.J Tehran Heart Cent. 2020 Apr;15(2):50-56. doi: 10.18502/jthc.v15i2.4183. J Tehran Heart Cent. 2020. PMID: 33552194 Free PMC article.
References
-
- Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909–45. - PubMed
-
- Taggart DP, Boyle R, de Belder MA, Fox KA. The 2010 ESC/EACTS guidelines on myocardial revascularisation. Heart. 2011;97:445–6. - PubMed
-
- Gao RL. Current status and perspective of percutaneous coronary intervention in China. Chin Med J (Engl) 2006;119:531–2. - PubMed
-
- Gibson CM, Schömig A. Coronary and myocardial angiography: Angiographic assessment of both epicardial and myocardial perfusion. Circulation. 2004;109:3096–105. - PubMed
-
- TIMI Study Group. Definitions used in TIMI trials. [Last accessed on 2009 Jun 20]. Available from: http://www.timi.org .
LinkOut - more resources
Full Text Sources
Miscellaneous